Insider Holders & Insider Ownership - Pacira BioSciences Inc. (PCRX)

List of insiders holdings for Pacira BioSciences Inc.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time		Shares Owned
Directly
Indirectly		Total
Shares Owned		Filing
GORDON CARL L
Director		2011-02-10 18:47:360
2,828,941		2,828,941Form 4
KAILIAN VAUGHN M
GADICKE ANSBERT
Former 10% Owner		2013-03-13 12:32:230
2,790,479		2,790,479Form 4
HBM Healthcare Investments (Cayman) Ltd.
10% Owner		2014-03-17 17:50:001,667,307
0		1,667,307Form 13D
ORBIMED ADVISORS LLC
OrbiMed Capital GP III LLC
ISALY SAMUEL D
10% Owner		2012-09-28 17:25:591,620,000
0		1,620,000Form 13D
Sanderling Venture Partners VI LP
Sanderling VI Beteiligungs GmbH & Co KG
Sanderling Ventures Management VI
Sanderling VI Limited Partnership
SANDERLING VENTURE PARTNERS IV CO INVESTMENT FUND LP
MIDDLETON FRED A
10% Owner		2013-04-15 20:09:241,582,192
0		1,582,192Form 4/A
MPM BioVentures IV QP LP
MPM BioVentures IV GP LLC
MPM BioVentures IV LLC
MPM Asset Management Investors BV4 LLC
MPM BioVentures IV GmbH & Co. Beteiligungs KG
DOMBKOWSKI ASHLEY L
Vander Vort John
Scopa James Paul
St Peter Steven
Greene William
10% Owner		2013-03-21 16:20:401,420,406
0		1,420,406Form 13D
MPM BioVentures IV QP LP
MPM BioVentures IV GP LLC
MPM BioVentures IV LLC
MPM Asset Management Investors BV4 LLC
MPM BioVentures IV GmbH & Co. Beteiligungs KG
Foley Todd
Vander Vort John
Scopa James Paul
St Peter Steven
10% Owner		2013-03-21 16:20:401,420,406
0		1,420,406Form 13D
MPM BioVentures IV QP LP
Scopa James Paul
MPM BioVentures IV GP LLC
MPM BioVentures IV LLC
MPM Asset Management Investors BV4 LLC
MPM BioVentures IV GmbH & Co. Beteiligungs KG
Foley Todd
Vander Vort John
Former 10% Owner		2013-03-21 16:20:401,420,406
0		1,420,406Form 13D
EVNIN LUKE
Director		2013-06-13 15:52:107,000
824,255		831,255Form 4
Sanderling Venture Partners VI LP
Sanderling VI Beteiligungs GmbH & Co KG
Sanderling VI Limited Partnership
Sanderling Venture Partners VI Co Investment Fund LP
MIDDLETON FRED A
10% Owner		2013-04-15 20:10:26602,286
0		602,286Form 4/A
STACK DAVID M
CEO and Chairman		2023-06-16 17:40:44431,881
116,184		548,065Form 4
Wicki Andreas
Director		2021-03-16 21:12:350
451,324		451,324Form 4
Cross Shawn
Chief Financial Officer		2024-11-05 16:42:18275,000
0		275,000Form 4
Pratt John
General Manager, San Diego		2013-06-14 18:29:44261,982
0		261,982Form 4
GAUGLER DARYL
Chief Operating Officer		2024-12-16 16:13:40115,200
0		115,200Form 4
Lee Frank D.
Chief Executive Officer		2024-08-13 16:55:05107,784
0		107,784Form 4
WILLIAMS KRISTEN
Chief Administrative Officer		2024-06-13 18:12:47102,912
0		102,912Form 4
SLONIN JONATHAN
Chief Medical Officer		2024-08-02 18:00:5794,307
0		94,307Form 4
PATOU GARY
Chief Medical Officer		2014-08-08 16:31:5580,453
702		81,155Form 4
MIDDLETON FRED A
Director		2013-06-25 21:03:0770,399
0		70,399Form 4
Lambert William
SVP, Pharmaceutical Dev		2011-02-02 17:58:0569,487
0		69,487Form 3
Walters Mark
SVP, Technicnical Operations		2011-02-02 17:56:1669,487
0		69,487Form 3
Braunstein Scott
Chief Operating Officer		2018-01-05 19:47:1060,000
0		60,000Form 4
WINSTON ROY
Chief Medical Officer		2023-08-04 16:47:5252,440
0		52,440Form 4
Reinhart Charles A. III
Chief Financial Officer		2024-06-13 18:14:1651,867
0		51,867Form 4
LARANJEIRA CHARLES ANTHONY
Chief Technical Officer		2022-06-16 16:05:5150,752
0		50,752Form 4
Manning Donald C.
Chief Medical Officer		2021-06-11 20:35:4544,520
0		44,520Form 4
McLoughlin Dennis
Chief Customer Officer		2023-06-07 21:24:3738,115
0		38,115Form 4
RIKER LAUREN
Senior Vice President, Finance		2024-06-13 18:15:1538,075
0		38,075Form 4
Kronenfeld Mark A.
Director		2024-06-13 18:12:2437,081
0		37,081Form 4
Scranton Richard
Chief Scientific Officer		2019-11-12 17:10:0036,311
0		36,311Form 4
Ellis Ronald J. Jr.
Chief Strategy Officer		2023-06-07 21:20:4130,909
0		30,909Form 4
REINHARDT MAX
President, Rest of World		2023-06-07 21:28:1729,225
0		29,225Form 4
Scibetta James S
President		2017-06-07 19:00:2925,118
0		25,118Form 4
HASTINGS PAUL J
Director		2024-06-13 18:13:0024,903
0		24,903Form 4
CHRISTIE CHRISTOPHER
Director		2024-06-13 18:14:4622,670
0		22,670Form 4
PACE GARY W
Director		2024-03-08 17:33:5122,127
0		22,127Form 4
Greenstreet Yvonne
Director		2022-06-08 19:26:2821,472
0		21,472Form 4
LONGENECKER JOHN P PHD
Director		2022-03-07 20:03:4718,823
0		18,823Form 4
Brege Laura
Director		2024-08-19 08:25:4617,552
0		17,552Form 4
Young Alethia
Director		2024-06-13 18:13:1417,409
0		17,409Form 4
Ceesay Abraham
Director		2024-06-13 18:13:4717,409
0		17,409Form 4
Jones James B
SVP & Chief Medical Officer		2017-11-20 18:43:5316,823
0		16,823Form 4
Froimson Mark
Director		2024-08-12 20:33:2614,473
0		14,473Form 4
MOLLOY ANTHONY
Chief Lgl & Compliance Officer		2023-06-07 21:26:5912,877
0		12,877Form 4
WINGER DENNIS L
Director		2017-06-16 20:18:2410,204
0		10,204Form 4
BIGAL MARCELO
Director		2024-08-19 08:25:5510,142
0		10,142Form 4
Markvicka Taunia
SVP, Chief Commercial Officer		2015-03-19 18:59:558,579
230		8,809Form 4
YANG MICHAEL J.
Director		2024-08-14 16:35:097,230
0		7,230Form 4
Weiland Robert J.
Chief Commercial Officer		2018-06-06 20:11:055,088
0		5,088Form 4